Related Experiment Video
Updated: Aug 24, 2026
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
Bronchiolitis: assessment and evidence-based management
Dominic A Fitzgerald1, Henry A Kilham
1Department of Respiratory Medicine, The Children's Hospital at Westmead, Locked Bag 4001, Westmead, NSW 2145, Australia. dominif2@chw.edu.au
Insights
Viral bronchiolitis, often caused by respiratory syncytial virus, is a common infant hospitalization cause. Most infants experience mild illness and do not require antibiotics or specific respiratory treatments.
Area of Science:
- Pediatrics
- Infectious Diseases
- Respiratory Medicine
Background:
- Viral bronchiolitis is a leading cause of hospital admission in infants.
- Respiratory syncytial virus (RSV) is the primary pathogen responsible for most bronchiolitis cases.
- Secondary bacterial infections are uncommon and rarely necessitate antibiotic treatment.
Purpose of the Study:
- To review the current evidence regarding the management of viral bronchiolitis in infants.
- To identify factors associated with severe illness and hospital admission.
- To evaluate the efficacy of commonly used but potentially unnecessary treatments.
Main Methods:
- Literature review of existing studies on viral bronchiolitis management.
- Analysis of factors influencing disease severity and hospitalization risk.
- Assessment of the evidence for treatments like nebulized adrenaline, corticosteroids, and bronchodilators.
Main Results:
- The majority of infants with bronchiolitis present with mild symptoms manageable at home.
- Premature infants, those with cardiac/respiratory conditions, and neonates are at higher risk for hospitalization.
- Current evidence does not support the routine use of nebulized adrenaline, corticosteroids, or bronchodilators.
Conclusions:
- Most infants with viral bronchiolitis do not require hospitalization or specific medical interventions.
- Risk stratification is crucial for identifying infants who may need hospital admission.
- Established treatments lack proven efficacy for routine bronchiolitis management in infants.
Abstract:
Viral bronchiolitis is the commonest cause of hospital admission in young infants. Respiratory syncytial virus is responsible for most cases of bronchiolitis. Secondary bacterial infection is rare and antibiotics are seldom necessary. Most children with bronchiolitis develop only mild illness and can be managed at home. Infants born prematurely, those with pre-existing cardiac or respiratory disease, and infants in the first three months of life are more likely to need hospital admission. On current evidence, nebulised adrenaline, inhaled and systemic corticosteroids, and inhaled bronchodilators do not have a role in the routine management of infants with bronchiolitis.
Related Concept Videos
01:30Asthma-IV: Nursing Management
First, in...
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
01:30Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:30Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
01:29Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...